2017 Fiscal Year Final Research Report
Innate immune regulation in metabolic steatohepatitis and experimental therapeutics
| Project/Area Number |
15K09023
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Juntendo University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
山科 俊平 順天堂大学, 医学部, 准教授 (30338412)
今 一義 順天堂大学, 医学部, 准教授 (30398672)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
TAKEDA Kazuyoshi 順天堂大学, 医学(系)研究科(研究院), 准教授 (80272821)
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Keywords | 非アルコール性脂肪肝炎（NASH） / 自然免疫 / NKT細胞 / 腸内マイクロバイオーム / アミノ酸 / 免疫栄養 / 耐糖能異常 |
|---|
| Outline of Final Research Achievements |
In this study, we investigated the role of innate immune responses in metabolic steatohepatitis (MetSH), and evaluate the protective effect of amino acid on MetSH.In MetSH model KK-Ay mice, glycine ameliorated glucose intolerance, accompanied with changes in gut microbiota. Progressive depletion of hepatic NK and NKT cells, in combination with increases in myeloid suppressor cells, were observed in hepatocyte-specific Pten-KO mice, which spontaneously develop steatohepatitis and hepatocellular adenoma/carcinoma upon aging. Glycine also prevented steatohepatitis and tumorigenesis in Pten-KO mice. These findings clearly indicated that pharmaco-nutritional approach utilizing glycine is promising for prevention and treatment of MetSH including MetSH-related carcinogenesis.
|
| Free Research Field |
肝臓病学
|
